Novozymes is the world leader in bioinnovation.
Novozymes is a world leader in bioinnovation. Novozymes works with its partners to innovate new solutions and rethink industries around the world. Novozymes' industrial enzymes, microorganisms, biopolymers, and other proteins allow its customers to achieve more efficient use of raw materials, reduce energy consumption, replace traditional chemicals with more sustainable alternatives, and offer higher-quality products. Novozymes rethinks everyday products every day.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 28, 2002 | IPO | — | — | — | — | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 9, 2018
Plant Response
|
Series B | $6.90M | Agriculture | — |
Nov 26, 2015
Plant Response
|
Series A | $6.60M | Agriculture | — |
Nov 1, 2014
AgBiome
|
Series Unknown | $17.50M | Agriculture | — |
Novozymes has had 1 exits. Novozymes most notable exits include Plant Response
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Feb 25, 2022 | Plant Response | M&A | Agriculture | Detail |
Novozymes has acquired 16 organizations. Their most recent acquisition was Sybron Biochemicals on Jul 1, 2001. They acquired Sybron Biochemicals for 0.
Date
Company Name
|
Industry | Acquisition Type | Price | |
---|---|---|---|---|
Jul 1, 2001
Sybron Biochemicals
|
Biotechnology | acquisition | — | Detail |
Feb 6, 2006
Qingdao Huayuan Fine Bio-Products
|
Biotechnology | acquisition | — | Detail |
Sep 19, 2006
Delta Biotechnology
|
Biotechnology | acquisition | — | Detail |
Oct 2, 2006
Earth BioSciences
|
Biotechnology | acquisition | — | Detail |
Oct 31, 2007
Philom Bios
|
Biotechnology | acquisition | — | Detail |